Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)

PHASE3CompletedINTERVENTIONAL
Enrollment

725

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Attention Deficit/Hyperactivity Disorder
Interventions
DRUG

Placebo

Placebo Comparator: Placebo

DRUG

Ritalin LA 20 mg

Ritalin LA (a racemic mixture of d- and l-thre-Methylphenidate Hydrochloride (MPH), extended release hard capsules) taken orally once daily in doses of 40, 60, or 80 mg.

DRUG

Ritalin LA 30 mg

Ritalin LA (a racemic mixture of d- and l-thre-Methylphenidate Hydrochloride (MPH), extended release hard capsules) taken orally once daily in doses of 60, or 80 mg.

Trial Locations (68)

1180

Novartis Investigative Site, Uccle

2196

Novartis Investigative Site, Melrose Arch

2800

Novartis Investigative Site, Mechelen

3010

Novartis Investigative Site, Kessel-Lo

3070

Novartis Investigative Site, Kortenberg

3550

Novartis Investigative Site, Heusden-Zolder

3725

Novartis Investigative Site, Skien

3922

Novartis Investigative Site, Porsgrunn

8000

Novartis Investigative Site, Århus C

8310

Novartis Investigative Site, Bruges

10629

Novartis Investigative Site, Berlin

12200

Novartis Investigative Site, Berlin

19149

Novartis Investigative Site, Philadelphia

20259

Novartis Investigative Site, Hamburg

22926

Novartis Investigative Site, Ahrensburg

24105

Novartis Investigative Site, Kiel

26655

Novartis Investigative Site, Westerstede/Oldenburg

30625

Novartis Investigative Site, Hanover

32806

Novartis Investigative Site, Orlando

33173

Novartis Investigative Site, Miami

33407

Novartis Investigative Site, West Plam Beach

34208

Novartis Investigative Site, Bradenton

38444

Novartis Investigative Site, Wolfsburg

42301

Novartis Investigative Site, Owensboro

43210

Novartis Investigative Site, Columbus

45147

Novartis Investigative Site, Essen

48083

Novartis Investigative Site, Troy

55131

Novartis Investigative Site, Mainz

57076

Novartis Investigative Site, Siegen

58093

Novartis Investigative Site, Hagen

58103

Novartis Investigative Site, Fargo

60048

Novartis Investigative Site, Libertyville

65549

Novartis Investigative Site, Limburg

66421

Novartis Investigative Site, Homburg

68159

Novartis Investigative Site, Mannheim

71636

Novartis Investigative Site, Ludwigsburg

72205

Novartis Investigative Site, Little Rock

73112

Novartis Investigative Site, Oklahoma City

73479

Novartis Investigative Site, Ellwangen

76829

Novartis Investigative Site, Landau

77007

Novartis Investigative Site, Houston

77008

Novartis Investigative Site, Houston

79104

Novartis Investigative Site, Freiburg im Breisgau

79106

Novartis Investigative Site, Freiburg im Breisgau

80333

Novartis Investigative Site, München

89081

Novartis Investigative Site, Ulm

89119

Novartis Investigative Site, Las Vegas

89128

Novartis Investigative Site, Las Vegas

90210

Novartis Investigative Site, Beverly Hills

90419

Novartis Investigative Site, Nuremberg

96047

Novartis Investigative Site, Bamberg

97070

Novartis Investigative Site, Würzburg

98004

Novartis Investigative Site, Bellevue

98104

Novartis Investigative Site, Seattle

119074

Novartis Investigative Site, Singapore

91978-1522

Novartis Investigative Site, Spring Valley

08046

Novartis Investigative Site, Willingboro

0000

Novartis Investigative Site, Santa Fe de Antioquia

Unknown

Novartis Investigative Site, Antioquia

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Benoni

06618

Novartis Investigative Site, Naumburg

01129

Novartis Investigative Site, Dresden

04157

Novartis Investigative Site, Leipzig

0001

Novartis Investigative Site, Pretoria

972 35

Novartis Investigative Site, Luleå

211 53

Novartis Investigative Site, Malmo

141 86

Novartis Investigative Site, Stockholm

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY